Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Dickinson

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Natural Product Reports|January 1, 1993
Microbial pyran-2-ones and dihydropyran-2-onesJ M Dickinson
Tubercle|September 1, 1987
In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteriaJ M Dickinson, D A Mitchison
Tubercle|June 1, 1990
In vitro activities against mycobacteria of two long-acting rifamycins, FCE22807 and CGP40/469A (SPA-S-565)J M Dickinson, D A Mitchison
Tubercle|December 1, 1976
Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutolJ M Dickinson, D A Mitchison
Tubercle|March 1, 1970
Suitability of rifampicin for intermittent administration in the treatment of tuberculosisJ M Dickinson, D A Mitchison
Tubercle|June 1, 1987
In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Bulletin of the International Union Against Tuberculosis|January 1, 1976
Experimental investigations of bacteriological mechanisms in short course chemotherapyJ M Dickinson, D A Mitchison
The American Review of Respiratory Disease|April 1, 1981
Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Tubercle|September 1, 1987
In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Postgraduate Medical Journal|November 1, 1971
Laboratory aspects of intermittent drug therapyD A Mitchison, J M Dickinson
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Natural Product Reports|January 1, 1993
Microbial pyran-2-ones and dihydropyran-2-onesJ M Dickinson
Tubercle|September 1, 1987
In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteriaJ M Dickinson, D A Mitchison
Tubercle|June 1, 1990
In vitro activities against mycobacteria of two long-acting rifamycins, FCE22807 and CGP40/469A (SPA-S-565)J M Dickinson, D A Mitchison
Tubercle|December 1, 1976
Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutolJ M Dickinson, D A Mitchison
Tubercle|March 1, 1970
Suitability of rifampicin for intermittent administration in the treatment of tuberculosisJ M Dickinson, D A Mitchison
Tubercle|June 1, 1987
In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Bulletin of the International Union Against Tuberculosis|January 1, 1976
Experimental investigations of bacteriological mechanisms in short course chemotherapyJ M Dickinson, D A Mitchison
The American Review of Respiratory Disease|April 1, 1981
Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Tubercle|September 1, 1987
In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Postgraduate Medical Journal|November 1, 1971
Laboratory aspects of intermittent drug therapyD A Mitchison, J M Dickinson
Pageof 5